Metropolitan Life Insurance Company (MetLife)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,642
| Closed | -$73.4K | – | 2841 |
|
|
2021
Q3 | $73.4K | Buy |
+1,642
| New | +$73.4K | ﹤0.01% | 2683 |
|
|
2021
Q2 | – | Sell |
-1,076
| Closed | -$80.5K | – | 2904 |
|
|
2021
Q1 | $80.5K | Sell |
1,076
-175
| -14% | -$13.1K | ﹤0.01% | 2472 |
|
|
2020
Q4 | $136K | Hold |
1,251
| – | – | ﹤0.01% | 2190 |
|
|
2020
Q3 | $111K | Hold |
1,251
| – | – | ﹤0.01% | 2159 |
|
|
2020
Q2 | $133K | Buy |
1,251
+28
| +2% | +$2.98K | ﹤0.01% | 2081 |
|
|
2020
Q1 | $72.5K | Buy |
+1,223
| New | +$72.5K | ﹤0.01% | 2236 |
|
|
2019
Q4 | – | Sell |
-1,329
| Closed | -$138K | – | 2568 |
|
|
2019
Q3 | $138K | Buy |
1,329
+1,039
| +358% | +$108K | ﹤0.01% | 2123 |
|
|
2019
Q2 | $26.8K | Buy |
+290
| New | +$26.8K | ﹤0.01% | 2572 |
|
|
2018
Q4 | – | Sell |
-926
| Closed | -$110K | – | 2578 |
|
|
2018
Q3 | $110K | Hold |
926
| – | – | ﹤0.01% | 2398 |
|
|
2018
Q2 | $94.5K | Buy |
+926
| New | +$94.5K | ﹤0.01% | 2350 |
|
|
2017
Q3 | – | Sell |
-970
| Closed | -$156K | – | 2540 |
|
|
2017
Q2 | $156K | Buy |
+970
| New | +$156K | ﹤0.01% | 2463 |
|